日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer

ESR1突变转移性乳腺癌中与依拉司特疗效相关的临床和基因组因素

Lloyd, Maxwell R; Weipert, Caroline M; Ali, Azka; Solomon, Sheila R; Saha, Jayati; Lipsyc-Sharf, Marla D; Hamilton, Erika P; Kalinsky, Kevin; Brufsky, Adam M; Bardia, Aditya; Zhang, Nicole; Wander, Seth A

Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer

微卫星稳定型结直肠癌靶向治疗后获得高肿瘤突变负荷和免疫治疗活性

Yeh, Celine; Artz, Oliver; Zhang, Haochen; Karnoub, Elias-Ramzey; Ntiamoah, Peter; Weipert, Caroline; Walch, Henry; Harrold, Emily; Keane, Fergus; Chalasani, Sree; Segal, Neil H; Foote, Michael B; Cercek, Andrea; Pagano, Andrew; Maron, Steven B; Diaz, Luis A Jr; Iacobuzio-Donahue, Christine A; Shia, Jinru; Rousseau, Benoit; Yaeger, Rona

Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.

在癌症实验模型中,通过定制化学诱变诱导错配修复缺陷基因型。

Rousseau Benoit, Patel Mitesh, Artz Oliver, Vlachos Georgios, Patel Shrey, Hayatt Omar, Argilés Guillem, Foote Michael B, Luo Lingqi, Shah Rachna, Mehta Shub, Rangavajhula Karthik, Stewart Caitlin M, Gerber Drew, Bhattacharya Rohini, Stephens Dennis, Mieles David, Randrian Violaine, Abdelfattah Somer, Zhang Lin, Membreno-Berganza Nathalie, Lamendola-Essel Michelle F, Piastra-Facon Florence, Vidal Joana, Johannet Paul, Lu Steve, White James R, Maron Steven B, Barlas Afsar, Weipert Caroline M, Rosiek Eric, Zhang Taotao, He Bing, Monette Sebastien, Qu Rui, Fidele Deborah, Bowker Sydney, Kahn Alec, Vitiello Pietro Paolo, Germano Giovanni, Bardelli Alberto, Mandal Rajarsi, Ma Xiaoxiao, Chan Tim A, Lu Sydney, Cercek Andrea, Abdel-Wahab Omar, de Stanchina Elisa, Segal Neil H, Diaz Luis A Jr

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.

从临床到实验室的转化分析:激素受体阳性转移性乳腺癌中 NF1 改变和 CDK4/6 抑制剂耐药性

Lloyd Maxwell R, Chica-Parrado Rosario, Weipert Caroline M, Knepper Todd C, Podany Emily L, Napolitano Fabiana, Ye Dan, Lin Chang-Ching, Uemoto Yasuaki, Liao Jiemin, Wegrzyn Claire, Walko Christine M, Ryan Lianne Y, Keenan Jennifer C, Medford Arielle J, Liu Shiyuan A, Wulf Gerburg M, Clifton Katherine K, Ma Cynthia X, Han Hyo S, Zhang Nicole, Ellisen Leif W, Bardia Aditya, Arteaga Carlos L, Hanker Ariella B, Wander Seth A

A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2

一项针对携带 ATM、BRCA1、BRCA2、PALB2 和 CHEK2 致病性变异的晚期胰腺癌患者的 Niraparib II 期试验

Huffman, Brandon M; Diossy, Miklos; Yurgelun, Matthew B; Horick, Nora; Li, Yvonne Y; Crowdis, Jett; Nguyen, Huy; Parmar, Kalindi; Kochupurakkal, Bose S; Vonk, Leonard; Lam, Helen; Ramsey, Kaitlyn; Andrews, Elizabeth; Loeb, Sarah C; Culnane, Leigh; Biller, Leah H; Bullock, Andrea J; Enzinger, Andrea; Giannakis, Marios; Jackson, Nadine A; Ng, Kimmie; Nowak, Jonathan A; Patel, Anuj K; Perez, Kimberly J; Rattani, Ahmed; Rubinson, Douglas A; Schlechter, Benjamin L; Singh, Harshabad; Cai, Mingyang; Raghavan, Srivatsan; Clark, Jefferey W; Peters, Mary Linton; Weipert, Caroline M; Wolpin, Brian M; D'Andrea, Alan D; Shapiro, Geoffrey I; Aguirre, Andrew J; Szallasi, Zoltan; Cleary, James M

TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

转移性乳腺癌患者中TOP1突变和抗体药物偶联物的交叉耐药性

Abelman Rachel O, Wu Bogang, Barnes Haley, Medford Arielle, Norden Bryanna, Putur Annika, Bitman Elena, Thant Win, Liu Ting, Weipert Caroline, Fell Geoffrey, Spring Laura M, Wander Seth A, Moy Beverly, Vidula Neelima, Isakoff Steven J, Varkaris Andreas, Juric Dejan, Corcoran Ryan B, Ellisen Leif W, Bardia Aditya

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

胰腺导管腺癌患者循环游离DNA中ERBB2(HER2)扩增和共存的KRAS改变与HER2抑制剂疗效的关系

Barzi, Afsaneh; Weipert, Caroline M; Espenschied, Carin R; Raymond, Victoria M; Wang-Gillam, Andrea; Nezami, Mohammad Amin; Gordon, Eva J; Mahadevan, Daruka; Mody, Kabir

Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer

通过靶向血浆基因分型检测转移性乳腺癌中的微卫星不稳定性高(MSI-H)状态

Vidula, Neelima; Lipman, Andrew; Kato, Shumei; Weipert, Caroline; Hesler, Katherine; Azzi, Georges; Elkhanany, Ahmed; Juric, Dejan; Rodriguez, Estelamari; Faulkner, Colleen; Makhlouf, Paul; Price, Kristin; O'Shaughnessy, Joyce; Bardia, Aditya

Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations

在71301例患者队列中,无细胞循环肿瘤DNA中ARID1A突变的患病率及其与驱动基因共突变的关联

Kurzrock, Razelle; Aggarwal, Charu; Weipert, Caroline; Kiedrowski, Lesli; Riess, Jonathan; Lenz, Heinz-Josef; Gandara, David

Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma

晚期肝细胞癌血液肿瘤突变负荷的特征和预测因子

Franses, Joseph W; Lim, Mir; Burgoyne, Adam M; Mody, Kabir; Lennerz, Jochen; Chang, Jeremy; Imperial, Robin; Dybel, Stacey N; Dinh, Thi M; Masannat, Jude; Weipert, Caroline M; Hsiehchen, David